Liaise with pathologists to refine understanding of the prostate-specific antigen test

Kenneth A Sikaris
Med J Aust 2014; 200 (10): . || doi: 10.5694/mja14.00048
Published online: 2 June 2014

In reply: It is interesting that in the debate on prostate cancer screening, positions are not as far apart as a “debate” implies. I agree with Del Mar and colleagues that all the existing trials have “serious potential methodological flaws” and therefore cannot be taken as evidence that prostate-specific antigen (PSA) screening is effective — nor that it is ineffective. Both sides of the “debate” are consistent with the recent National Health and Medical Research Council conclusion that PSA testing may help some men and may not help others.

  • Kenneth A Sikaris1,2

  • 1 Melbourne Pathology, Melbourne, VIC.
  • 2 University of Melbourne, Melbourne, VIC.


Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.